Jacobs Levy Equity Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.45M Sell
192,070
-74,698
-28% -$565K 0.01% 684
2025
Q1
$1.47M Sell
266,768
-23,243
-8% -$128K 0.01% 726
2024
Q4
$1.67M Buy
290,011
+98,285
+51% +$565K 0.01% 632
2024
Q3
$1.99M Sell
191,726
-2,841
-1% -$29.4K 0.01% 605
2024
Q2
$2.52M Sell
194,567
-163
-0.1% -$2.11K 0.01% 563
2024
Q1
$3.4M Sell
194,730
-366,291
-65% -$6.4M 0.02% 498
2023
Q4
$5.28M Buy
561,021
+215,370
+62% +$2.03M 0.03% 418
2023
Q3
$3.86M Sell
345,651
-1,697
-0.5% -$19K 0.02% 427
2023
Q2
$7.43M Buy
347,348
+893
+0.3% +$19.1K 0.04% 322
2023
Q1
$14M Sell
346,455
-2,603
-0.7% -$105K 0.09% 238
2022
Q4
$16.2M Sell
349,058
-3,245
-0.9% -$151K 0.11% 215
2022
Q3
$18.3M Buy
352,303
+54,771
+18% +$2.84M 0.14% 180
2022
Q2
$14.1M Buy
297,532
+19,109
+7% +$903K 0.11% 222
2022
Q1
$19.8M Buy
278,423
+8,293
+3% +$590K 0.13% 182
2021
Q4
$20.2M Buy
270,130
+16,316
+6% +$1.22M 0.14% 182
2021
Q3
$14.4M Sell
253,814
-5,739
-2% -$326K 0.1% 236
2021
Q2
$11.4M Buy
259,553
+17,296
+7% +$761K 0.08% 268
2021
Q1
$11.9M Sell
242,257
-6,063
-2% -$299K 0.09% 255
2020
Q4
$10.5M Sell
248,320
-7,744
-3% -$326K 0.09% 252
2020
Q3
$11.7M Sell
256,064
-8,197
-3% -$375K 0.12% 189
2020
Q2
$13.3M Buy
264,261
+93,476
+55% +$4.69M 0.14% 173
2020
Q1
$8.78M Buy
170,785
+84,998
+99% +$4.37M 0.11% 199
2019
Q4
$5.3M Buy
85,787
+14,413
+20% +$890K 0.05% 358
2019
Q3
$4.29M Buy
71,374
+13,370
+23% +$803K 0.05% 360
2019
Q2
$4.89M Buy
+58,004
New +$4.89M 0.07% 349
2018
Q4
Sell
-26,822
Closed -$2.29M 1003
2018
Q3
$2.29M Buy
26,822
+14,145
+112% +$1.21M 0.03% 486
2018
Q2
$1.47M Sell
12,677
-16,043
-56% -$1.86M 0.02% 574
2018
Q1
$2.32M Sell
28,720
-680
-2% -$55K 0.04% 442
2017
Q4
$1.73M Buy
+29,400
New +$1.73M 0.03% 492
2016
Q2
Sell
-13,992
Closed -$411K 1170
2016
Q1
$411K Buy
+13,992
New +$411K 0.01% 779